UMIN-CTR Clinical Trial

Basic information
Public title	Trial of the efficacy of food ingredients on knee flexibility in healthy men and women (SWE-2021-04-HBLOCO)
Acronym	Trial of the efficacy of food ingredients on knee flexibility
Scientific Title	Trial of the efficacy of food ingredients on knee flexibility
Scientific Title:Acronym	Trial of the efficacy of food ingredients on knee flexibility
Region	Japan

Condition
Condition	Not applicable
Classification by specialty	Adult
Classification by malignancy	Others
Genomic information	NO

Objectives
Narrative objectives1	To evaluate the effect of food ingredients on knee flexibility
Basic objectives2	Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes	Knee flexion angle
Key secondary outcomes

Base
Study type	Interventional

Study design
Basic design	Parallel
Randomization	Randomized
Randomization unit	Individual
Blinding	Double blind -all involved are blinded
Control	Placebo
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms	2
Purpose of intervention	Prevention
Type of intervention	Food
Interventions/Control_1	Intake of the test foods (12 weeks)
Interventions/Control_2	Intake of the control foods (12 weeks)
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit	40 years-old <=
Age-upper limit	64 years-old >=
Gender	Male and Female
Key inclusion criteria	(1) Healthy men and women aged 40 to 64 years. (2) Person with a knee flexion angle of less than 130 degrees. (3) Person who has knee pain. (4) Person who can understand the purpose and content of this study and agree in writing to participate in this study.
Key exclusion criteria	(1) Presence of disease in locomotor organs affecting the efficacy assessment of this study. (2) Person whose keep irregular hours such as shift work. (3) Use of product affecting the data of this study, such as food for specified health use, food with function claims, and medicine. (4) Presence of previous and present serious disease such as cardiac affection, liver disorder, kidney disorder, cardiovascular disorder, lung disorder, diabetes mellitus. (5) Investigator's judgment for other reason.
Target sample size	140

Research contact person
Name of lead principal investigator	1st name Hiroshi Middle name Last name Watanabe
Organization	Suntory Wellness Limited
Division name	Institute For Health Care Science
Zip code	619-0284
Address	8-1-1 Seikadai, Seika-cho, Soraku-gun, Kyoto, Japan.
TEL	050-3182-0593
Email	H_Watanabe@suntory.co.jp

Public contact
Name of contact person	1st name Saori Middle name Last name Omae
Organization	Suntory Wellness Limited
Division name	Institute For Health Care Science
Zip code	619-0284
Address	8-1-1 Seikadai, Seika-cho, Soraku-gun, Kyoto, Japan.
TEL	050-3182-8180
Homepage URL
Email	Saori_Omae@suntory.co.jp

Sponsor
Institute	Suntory Wellness Limited
Institute
Department

Funding Source
Organization	None
Organization
Division
Category of Funding Organization	Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization	Medical Station Clinic Research Ethics Committee
Address	3-12-8, Takaban, Meguroku, Tokyo
Tel	03-6452-2712
Email	nakagawa.akiko297@eps.co.jp

Secondary IDs
Secondary IDs	NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information	2022 Year 08 Month 03 Day

Related information
URL releasing protocol
Publication of results	Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status	Preinitiation
Date of protocol fixation	2022 Year 07 Month 14 Day
Date of IRB
Anticipated trial start date	2022 Year 08 Month 04 Day
Last follow-up date	2022 Year 12 Month 24 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date	2022 Year 07 Month 25 Day
Last modified on	2022 Year 07 Month 25 Day

Link to view the page
URL(English)	https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000055217

Research Plan
Registered date	File name

Research case data specifications
Registered date	File name

Research case data
Registered date	File name

Contact us.